Wall Street Analysts Believe Prestige Consumer Healthcare (PBH) Could Rally 26.06%: Here's is How to Trade

Group 1 - Prestige Consumer Healthcare (PBH) closed at $60.82, with a 1.5% gain over the past four weeks, and a mean price target of $76.67 suggests a 26.1% upside potential [1] - The mean estimate includes three short-term price targets with a standard deviation of $9.87, indicating variability; the lowest estimate is $70.00 (15.1% increase), while the highest is $88.00 (44.7% increase) [2] - Analysts show strong agreement on PBH's ability to report better earnings, with a positive trend in earnings estimate revisions correlating with potential stock upside [4][11] Group 2 - The Zacks Consensus Estimate for the current year has increased by 1% over the last 30 days, with three estimates moving higher and no negative revisions [12] - PBH holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential upside [13] - While the consensus price target may not be a reliable indicator of the extent of PBH's gains, it does provide a directional guide for price movement [14]